Plecanatide
467426-54-6
Pharmaceutical Grade
99%
Hangzhou
fullas
1g
2026-03-04
GLP-1,Tirzepatide,Retatrutide,MOTS-c
-
Product Description
-
Seller Information
-
DescriptionPlecanatide is an oral guanylate cyclase-C agonist that is being developed by Synergy Pharmaceuticals for the treatment of gastrointestinal disorders, such as chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). It is a synthetic analogue of human uroguanylin, a 16 amino acid peptide that regulates ion and fluid transport in the gastrointestinal tract. In January 2017, plecanatide received its first global approval in the USA for the treatment of adult patients with CIC. Plecanatide is undergoing phase III investigation in IBS-C.Basic Info
-
Product Name:
Plecanatide
Other Name:Plecanatide;ASN-ASP-GLU-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU(DISULFIDE BOND CYS1&CYS3,CYS2&CYS4);Plecanatide Impurtiy;L-Leucine, L-asparaginyl-L-α-aspartyl-L-α-glutamyl-L-cysteinyl-L-α-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4→12),(7→15)-bis(disulfide);Plecanatide impurity;Plecanatide USP/EP/BP;Prikanatide;ATCH(1-39)
CAS No.:467426-54-6
Molecular Formula:C65H104N18O26S4
InChIKeys:NSPHQWLKCGGCQR-DLJDZFDSSA-N
Molecular Weight:1681.89
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.47±0.1 g/cm3(Predicted)
Boiling Point:2120.0±65.0 °C(Predicted)
PKA:3.61±0.21(Predicted)
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
GLP-1,Tirzepatide,Retatrutide,MOTS-c
-
Location:
5 Euro America Financial City EFC Yuhang District Hangzhou China 311100 P.R.China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment
-
Average lead Time:
1
-
Year of Establishment:
2023
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product